ArticleJournal of multimorbidity and comorbidity
Differences in clinical profiles and cancer incidence among patients with type 2 diabetes in primary care: Comparison between multidisciplinary and usual management.
Article in Journal of multimorbidity and comorbidity. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multidisciplinary diabetes management has been designed to reduce the risk of diabetes-associated complications. Nevertheless, it remains underexplored whether multidisciplinary management may provide the added benefits of lowering cancer risk. This study aims to compare differences in clinical profiles and cancer incidence between patients receiving multidisciplinary and standard management in primary care. Methods: This retrospective cohort study identified patients who attended general outpatient clinics between year 1997 and 2021 without cancer history using territory-wide electronic health records of Hong Kong. Patients were followed up until December 31st, 2021. Cox regression weighted with inverse probability of treatment was applied to compare the risk of site-specific cancers (colon and rectum, liver, pancreas, stomach, bladder, kidney, and lung) between patients with usual diabetes care (n=25,301), multidisciplinary diabetes management (n=66,382), and those without diabetes (n=54,376). Results: The risk of developing liver and pancreatic cancers appeared to be attenuated in patients who received multidisciplinary diabetes care, when compared to those with usual care alone (aHRs for liver: 1.90, 95%CI 1.26-2.86 vs 2.26, 95%CI 1.47-3.46; pancreas: 3.47, 95%CI 1.41-8.53 vs 5.57, 95%CI 2.15-14.45), with reference to non-diabetes. Patients with usual diabetes care showed a higher risk of gastric cancer in unweighted model, but the association disappeared in weighted model. Overall, patients who received multidisciplinary diabetes management tended to be younger with less comorbidities. Conclusion: The risk of liver and pancreatic cancers appeared to be mitigated in patients receiving multidisciplinary diabetes care. Further studies are warranted to evaluate whether multidisciplinary management may provide additional benefits of cancer prevention.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.